AMPICILLIN-CYCLOHEXYLIDENE-SUCCINIMIDOMETHYLESTER-HYDROCHLORIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8D0Yx8zrHaE |
|---|---|
| InChI | InChI=1S/C27H32N4O6S.ClH/c1-27(2)21(26(36)37-14-30-18(32)13-17(23(30)34)15-9-5-3-6-10-15)31-24(35)20(25(31)38-27)29-22(33)19(28)16-11-7-4-8-12-16;/h4,7-8,11-12,19-21,25H,3,5-6,9-10,13-14,28H2,1-2H3,(H,29,33);1H/t19-,20+,21-,25?;/m0./s1 |
| InChIKey | XQVVUDRSGJYINN-CHEOKKHZSA-N |
| Mol Weight | 577.1 g/mol |
| Molecular Formula | C27H33ClN4O6S |
| Exact Mass | 576.180934 g/mol |
| Parent InChIKey | OYZLYPYGLRGFAC-UZNLOIBPSA-N |
| Enantiomer InChIKey | XQVVUDRSGJYINN-YYHZLDICSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
AMPICILLIN-[4-(3-DIMETHYLAMINOPROPOXY)-BENZYLIDENE]-SUCCINIMIDOMETHYLESTER-HYDROCHLORIDE
AMPICILLIN-PHTHALIMIDOMETHYLESTER-HYDROCHLORIDE
N-ACETYLAMPICILLIN-PHTHALIMIDOMETHYLESTER
TALAMPICILLIN;HYDROCHLORIDE
Amoxicillin trihydrate/Clavulanate potassium
6-[2-[2-(2-HYDROXYETHYLCARBAMOYL)-3,6-DIOXOCYCLOHEXA-1,4-DIENYLAMINO]-2-PHENYL-ACETYLAMINO]-PENICILLANIC-ACID
Mezlocillin anion
mezlocillin
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(difluoromethyl)-3-methyl-7-oxo-6-[(phenoxyacetyl)amino]-, phenylmethyl ester, [2S-(2.alpha.,3.alpha.,5.alpha.,6.beta.)]-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(3-amino-3-oxo-1-propenyl)-3-methyl-7-oxo-6-[(phenoxyacetyl)amino]-, phenylmethyl ester, [2S-[2.alpha.,3.beta.(Z),5.alpha.,6.beta.]]-
| Title | Journal or Book | Year |
|---|---|---|
| Syntheses and hydrolysis of basic and dibasic ampicillin esters tailored for intracellular accumulation | Bioorganic & Medicinal Chemistry | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.